Who should not take Edurant?

The following people should not take Edurant (rilpivirine), a drug that is given with other medications to treat infection with human immunodeficiency virus type 1 (HIV-1):
  • Anyone who has already been treated for HIV-1 infection. Edurant is approved by the U.S. Food and Drug Administration (FDA) for people who have contracted HIV-1, but who have not been treated for HIV infection in the past.
  • Children. Edurant is FDA-approved for use only in adults. Safety and effectiveness in children has not been proven.
Researchers aren't sure whether Edurant is safe in pregnant women. Women who are pregnant or who may become pregnant must carefully weigh the potential risks and benefits of the drug with their doctors. People who have a history of liver problems, mental health problems or other medical issues may also not be good candidates for treatment with Edurant. Be sure that your doctor is aware of any medical problems you have now or had in the past.

Continue Learning about Anti-HIV Agent

Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.